HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intestinal bypass for morbid obesity: a consecutive personal series.

Abstract
Forty-five patients who underwent end-to-side jejunoileal bypass, with 51 cm in circuit, were followed up from 8 months to 8 years (average 3.4 years). There was no early or late mortality but morbidity was considerable; it included inadequate weight loss or late gain in 22%, malnutrition and liver failure in 11%, severe diarrhea and electrolyte imbalance in 11%. Cholelithiasis and wound complications also occurred. Reanastomosis was necessary in 13% (six patients). The result of the bypass was good in only 20%, satisfactory in 44% and unsatisfactory in 36%. This type of bypass is not adequate treatment for morbid obesity because the proportion of unsatisfactory results (36%) is too high and the number of good results too low and because the outcome is unpredictable. The complication of malnutrition characterized by a decline in body cell mass, an expansion of the extracellular mass and an increase in the ratio of total exchangeable sodium to total exchangeable potassium is quickly and effectively treated by intravenous administration of amino acids or protein hydrolysates. Long-term management of protein malnutrition requires a high protein diet (100 g/d) or reanastomosis.
AuthorsL D MacLean, G Rochon, M Munro, K E Watson, H M Shizgal
JournalCanadian journal of surgery. Journal canadien de chirurgie (Can J Surg) Vol. 23 Issue 1 Pg. 54-9 (Jan 1980) ISSN: 0008-428X [Print] Canada
PMID7363159 (Publication Type: Journal Article)
Chemical References
  • Sodium
  • Potassium
Topics
  • Adult
  • Body Weight
  • Female
  • Follow-Up Studies
  • Humans
  • Ileum (surgery)
  • Jejunum (surgery)
  • Male
  • Middle Aged
  • Obesity (diagnosis, therapy)
  • Postoperative Complications
  • Potassium (metabolism)
  • Sodium (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: